Kamostat (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kamostat" in Turkish language version.

refsWebsite

Global rank Turkish rank

6doi.org

2^nd place

4^th place

6nih.gov

4^th place

11^th place

3web.archive.org

1^st place

1drugs.com

399^th place

156^th place

1archive.org

6^th place

1cell.com

2,814^th place

2,465^th place

1shijiebiaopin.net

low place

archive.org

Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S (Haziran 2012). "Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry". J. Virol. 86 (12). ss. 6537-45. doi:10.1128/JVI.00094-12. PMC 3393535 $2. PMID 22496216.

cell.com

Hoffman, Markus (5 Mart 2020). "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor". Cell. 14 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2020.

doi.org

Okuno, M.; Kojima, S.; Akita, K.; Matsushima-Nishiwaki, R.; Adachi, S.; Sano, T.; Takano, Y.; Takai, K.; Obora, A.; Yasuda, I.; Shiratori, Y.; Okano, Y.; Shimada, J.; Suzuki, Y.; Muto, Y.; Moriwaki, Y. (2002). "Retinoids in liver fibrosis and cancer". Frontiers in Bioscience. 7 (4). ss. d204-18. doi:10.2741/A775. PMID 11779708.
Hsieh, H. P.; Hsu, J. T. (2007). "Strategies of development of antiviral agents directed against influenza virus replication". Current Pharmaceutical Design. 13 (34). ss. 3531-42. doi:10.2174/138161207782794248. PMID 18220789.
Kitamura, K.; Tomita, K. (2012). "Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension". Clinical and Experimental Nephrology. 16 (1). ss. 44-8. doi:10.1007/s10157-011-0506-1. PMID 22038264.
Zhou, Y.; Vedantham, P.; Lu, K.; Agudelo, J.; Carrion Jr, R.; Nunneley, J. W.; Barnard, D.; Pöhlmann, S.; McKerrow, J. H.; Renslo, A. R.; Simmons, G. (2015). "Protease inhibitors targeting coronavirus and filovirus entry". Antiviral Research. Cilt 116. ss. 76-84. doi:10.1016/j.antiviral.2015.01.011. PMC 4774534 $2. PMID 25666761.
Ueda, M.; Uchimura, K.; Narita, Y.; Miyasato, Y.; Mizumoto, T.; Morinaga, J.; Hayata, M.; Kakizoe, Y.; Adachi, M.; Miyoshi, T.; Shiraishi, N.; Kadowaki, D.; Sakai, Y.; Mukoyama, M.; Kitamura, K. (2015). "The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects". Nephron. 129 (3). ss. 223-32. doi:10.1159/000375308. PMID 25766432.
Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S (Haziran 2012). "Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry". J. Virol. 86 (12). ss. 6537-45. doi:10.1128/JVI.00094-12. PMC 3393535 $2. PMID 22496216.

drugs.com

"Camostat". drugs.com. 5 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mart 2020.

nih.gov

ncbi.nlm.nih.gov

Okuno, M.; Kojima, S.; Akita, K.; Matsushima-Nishiwaki, R.; Adachi, S.; Sano, T.; Takano, Y.; Takai, K.; Obora, A.; Yasuda, I.; Shiratori, Y.; Okano, Y.; Shimada, J.; Suzuki, Y.; Muto, Y.; Moriwaki, Y. (2002). "Retinoids in liver fibrosis and cancer". Frontiers in Bioscience. 7 (4). ss. d204-18. doi:10.2741/A775. PMID 11779708.
Hsieh, H. P.; Hsu, J. T. (2007). "Strategies of development of antiviral agents directed against influenza virus replication". Current Pharmaceutical Design. 13 (34). ss. 3531-42. doi:10.2174/138161207782794248. PMID 18220789.
Kitamura, K.; Tomita, K. (2012). "Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension". Clinical and Experimental Nephrology. 16 (1). ss. 44-8. doi:10.1007/s10157-011-0506-1. PMID 22038264.
Zhou, Y.; Vedantham, P.; Lu, K.; Agudelo, J.; Carrion Jr, R.; Nunneley, J. W.; Barnard, D.; Pöhlmann, S.; McKerrow, J. H.; Renslo, A. R.; Simmons, G. (2015). "Protease inhibitors targeting coronavirus and filovirus entry". Antiviral Research. Cilt 116. ss. 76-84. doi:10.1016/j.antiviral.2015.01.011. PMC 4774534 $2. PMID 25666761.
Ueda, M.; Uchimura, K.; Narita, Y.; Miyasato, Y.; Mizumoto, T.; Morinaga, J.; Hayata, M.; Kakizoe, Y.; Adachi, M.; Miyoshi, T.; Shiraishi, N.; Kadowaki, D.; Sakai, Y.; Mukoyama, M.; Kitamura, K. (2015). "The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects". Nephron. 129 (3). ss. 223-32. doi:10.1159/000375308. PMID 25766432.
Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S (Haziran 2012). "Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry". J. Virol. 86 (12). ss. 6537-45. doi:10.1128/JVI.00094-12. PMC 3393535 $2. PMID 22496216.

shijiebiaopin.net

"Arşivlenmiş kopya" (PDF). 27 Eylül 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 22 Mart 2020.

web.archive.org

"Camostat". drugs.com. 5 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mart 2020.
Hoffman, Markus (5 Mart 2020). "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor". Cell. 14 Mart 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Mart 2020.
"Arşivlenmiş kopya" (PDF). 27 Eylül 2020 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 22 Mart 2020.